Clinical Trial: Efficacy and Safety of Adalimumab for the Treatment of Ocular Inflammation

U.S., Nov. 4 -- ClinicalTrials.gov registry received information related to the study (NCT07913750) titled 'Efficacy and Safety of Adalimumab for the Treatment of Ocular Inflammation' on Oct. 27.

Brief Summary: This study aims to evaluate the clinical efficacy and safety of adalimumab in pediatric non-infectious uveitis and to generate domestic real-world evidence (RWE), thereby establishing a clinical foundation for label expansion and reimbursement coverage.

Study Start Date: Nov. 15

Study Type: INTERVENTIONAL

Condition: Non-infectious Anterior Uveitis Non-infectious Intermediate Uveitis Non-infectious Posterior Uveitis Panuveitis

Intervention: DRUG: Adalimumab PFS and Pen

Yuflyma Pen Inj. (recombinant adalimumab biosimilar, Cellt...